tirzepatide and asthma medication Semaglutide vs for Weight Loss Oral Tirzepatide Pill: FDA Status

About 50% stopped taking the medications within six months of conception, about 34% stopped earlier than that, and 17% stopped after conception

N., Robinson, S., Kennedy-Martin, T., Poon, J

oral obesity drug market is already intensifying

OShea KM, Khairallah RJ, Sparagna GC, Xu W, Hecker PA, Robillard-Frayne I, Des Rosiers C, Kristian T, Murphy RC, Fiskum G, Stanley WC

GLP-1 risks: Temporary GI side effects (nausea, constipation), possible hair thinning from rapid weight loss, rare pancreatitis risk, gallbladder issues

Primary Benefits: FDA-approved (as Vyleesi) for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women